Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 38,900 shares of the firm’s stock in a transaction on Wednesday, January 22nd. The stock was purchased at an average cost of $0.77 per share, with a total value of $29,953.00. Following the completion of the transaction, the chief executive officer now owns 4,203,689 shares in the company, valued at $3,236,840.53. The trade was a 0.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link.
Grigorios Siokas also recently made the following trade(s):
- On Friday, January 17th, Grigorios Siokas purchased 29,158 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The shares were bought at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Down 0.8 %
COSM stock traded down $0.01 during mid-day trading on Thursday, hitting $0.77. The stock had a trading volume of 118,803 shares, compared to its average volume of 884,276. Cosmos Health Inc. has a 1-year low of $0.47 and a 1-year high of $1.58. The company has a fifty day moving average of $0.72 and a 200 day moving average of $0.91. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $17.79 million, a price-to-earnings ratio of -0.31 and a beta of 5.57.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- High Flyers: 3 Natural Gas Stocks for March 2022
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- GitLab: AI-Driven DevSecOps Innovation Sets It Apart
- Roth IRA Calculator: Calculate Your Potential Returns
- DigitalOcean’s AI Potential: A Game-Changer for Growth
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.